Velsof – Sofosbuvir & Velpatasvir 400 mg / 100 mg
Velsof is a combination medication for the treatment of hepatitis C and contains two active substances – the NS5A and NS5B protein inhibitors Velpatasvir and Sofosbuvir. It’s universal medication for the treatment of all hepatitis C virus genotypes 1-6. Depending on the genotype, the success rate ranges from 95-99%.